Navigation Links
GenVec Reports Second Quarter 2009 Financial Results
Date:8/6/2009

ting of the American Society for Clinical Oncology. The poster, entitled "Multi-Center Randomized Controlled Phase III Clinical Trial using TNFerade(TM) with Chemoradiation in Patients with Locally Advanced Pancreatic Cancer: Interim Analysis of Overall Survival," reported on results of an interim analysis from the PACT trial.

  • In June 2009, GenVec terminated its manufacturing agreement and its associated services schedule with Cobra BioManufacturing.

Vaccine Programs

  • GenVec expanded an existing contract with the PATH Malaria Vaccine Initiative (MVI) to support the development of vaccines to fight malaria through MVI and USAID funding. This contract is valued at approximately $2 million over two years.

  • GenVec received a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's malaria vaccine program. This grant, valued at approximately $600,000 over two years, will be used to identify new immunogenic antigens for malaria vaccine development.

Other Developments

  • GenVec strengthened its cash position by raising $6.0 million from a single institutional investor. Proceeds of this transaction, net of offering costs, totaled $5.5 million.

Conference Call Information

GenVec will hold a conference call at 10:00 a.m. EDT on Friday, August 7, 2009 to discuss the Company's second quarter results. To listen to the live conference call, please dial 888-679-8033 (U.S. or Canada) or 617-213-4846 (international) and use access code 57544597. Participants may pre-register for the call anytime at:

SOURCE GenVec, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. GenVec Expands Contract Supporting Malaria Vaccine Program
2. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
3. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
4. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
5. OncoGenex Reports Second Quarter 2009 Financial Results
6. Repligen Reports First Quarter Fiscal Year 2010 Financial Results
7. PDI Reports 2009 Second Quarter Financial Results
8. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
9. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
10. NxStage Reports Second Quarter 2009 Financial Results
11. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Standards and Technology (NIST) and California Institute of ... an atomic clock that is based on a ... microcomb clock, featured on the cover of the ... ,* is the first demonstration of all-optical control ... optical frequencies to lower microwave frequencies. (Optical frequencies ...
(Date:7/22/2014)... DALLAS , July 22, 2014   ... replacement therapy using natural, bio-identical hormone pellets, today ... , MD to the company.   Dr. Rouzier is ... training physician.      Dr. Rouzier was ... at UCLA and is a board certified emergency ...
(Date:7/22/2014)... 2014 Automated cell culture systems are ... cell culture. They allow production of optimum cells at ... in drug discovery and industries and biopharmaceutical companies. Cell ... iPSC research, cryobanking, cell-based assays, and cellular expression systems ... Analysts forecast the Global Cell Culture market ...
(Date:7/22/2014)... Philadelphia, PA (PRWEB) July 22, 2014 ... Science Center’s Board of Directors at its annual Shareholders ... and Chief Information Officer of The PFM Group, and ... The Science Center also announced the election of Michael ... as Board Vice Chair and Richard P. Jaffe, Esq., ...
Breaking Biology Technology:'Comb on a chip' powers new NIST/Caltech atomic clock design 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3
... N.Y., April 19, 2011 Today, H. Shep ... Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on ... (FAK) inhibitors for cancer, provided a company overview ... at the Celebration of Innovation Showcase 2011 hosted ...
... to commemorate the discovery of superconductivity by the Dutch ... from the Helmholtz-Zentrum Dresden-Rossendorf and the TU Dresden published ... B . Headed by Dr. Thomas Herrmannsdrfer, the ... examined a material consisting of the elements bismuth and ...
... Md., April 18, 2011 Accelovance, a privately ... "Best Contract Research Organization (CRO)" for a third ... week at the Gaylord National Hotel and Convention ... Excellence (ViE) Awards to honor and generate recognition ...
Cached Biology Technology:CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 2CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 3CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 4Ferromagnetism plus superconductivity 2Continued Recognition for Excellence; Accelovance Named 2011 "Best CRO" 2
(Date:7/23/2014)... over a 15-year period off the U.S. West Coast ... specific locations each year, according to a study published ... ONE by Ladd Irvine from Oregon State University ... human threats to the whale population. , The endangered ... the establishment of protections in the mid-1960s. Scientists suggest ...
(Date:7/23/2014)... super strength, but it also holds the promise of ... ability to convert sunlight into a clean, efficient alternative ... international group using spinach to study the proteins involved ... sun,s energy into carbohydrates used to power cellular processes. ... most efficient system ever built, capable of converting the ...
(Date:7/23/2014)... entire country in its grip is affecting more than the ... the proliferation of a heat-loving amoeba commonly found in warm ... the drought has made warmer than usual this year. , ... by this parasite after swimming in several area lakes. The ... and travels to the brain. Nose plugs can lower the ...
Breaking Biology News(10 mins):Blue whales' dangerous feeding grounds 2Spinach could lead to alternative energy more powerful than Popeye 2Diseases of another kind 2
... 2010 From April 8 to 10, 2010, 185 ... focus on advancing new tools to humanely and effectively ... Experts in reproductive biology and other related scientific disciplines ... experts in animal health drug development. Veterinary leaders joined ...
... the press for the Ecological Society of America,s (ESA) 95th ... Pittsburgh. The meeting, which has the theme "Global Warming: The ... a critical combination of more than 3,000 scientists, policy makers ... global warming and to discuss the ways in which climate ...
... who drink soda have less healthy diets through adolescence than their ... study. The ten-year study showed that girls who drank ... meet nutritional standards for the duration of the study, which ended ... five did not meet certain nutritional requirements, but their diets were ...
Cached Biology News:Momentum builds after 4th International Symposium on Pet Contraception 2Momentum builds after 4th International Symposium on Pet Contraception 3Ecological Society of America explores global warming at its 95th Annual Meeting 2Ecological Society of America explores global warming at its 95th Annual Meeting 3Early consumption of soda indicator of unhealthy diet 2Early consumption of soda indicator of unhealthy diet 3
... Probes is pleased to offer the ... ultrasensitive detection of primary amines. Developed ... University, the ATTO-TAG reagents are similar ... naphthalene-2,3-dicarboxaldehyde (NDA) and anthracene-2,3-dicarboxaldehyde, all of ...
... to offer the ATTO-TAG series of ... primary amines. Developed by Novotny and ... reagents are similar to the important ... anthracene-2,3-dicarboxaldehyde, all of which are also ...
...
Microlite 1+ 1x12 Strip assembled, flat bottom; the ideal vessel for low signal luminescent reactions, offering medium binding with enhanced dynamic range, extra high reflectivity and minimal cross t...
Biology Products: